NasdaqCM - Delayed Quote USD

NLS Pharmaceutics AG (NLSPW)

Compare
0.0114 +0.0013 (+12.87%)
At close: November 6 at 4:00 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
1,846.6410
9,276.6430
5,764.7100
1,211.5770
Total Liabilities Net Minority Interest
10,680.2040
5,995.8040
5,222.3220
10,195.6340
Total Equity Gross Minority Interest
-8,833.5630
3,280.8390
542.3880
-8,984.0570
Total Capitalization
-8,833.5630
3,280.8390
542.3880
-8,670.5790
Common Stock Equity
-8,833.5630
3,280.8390
542.3880
-8,984.0570
Net Tangible Assets
-8,833.5630
3,280.8390
542.3880
-8,984.0570
Working Capital
-6,096.4880
5,886.6850
3,319.6940
-7,007.2070
Invested Capital
-7,199.8170
3,280.8390
542.3880
-6,899.2560
Tangible Book Value
-8,833.5630
3,280.8390
542.3880
-8,984.0570
Total Debt
1,633.7460
--
--
2,084.8010
Net Debt
736.0660
--
--
1,991.0900
Share Issued
32,428.8930
32,428.8930
16,223.3890
11,779.2770
Ordinary Shares Number
32,428.8930
32,428.8930
16,223.3890
11,779.2770
12/31/2020 - 1/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers